Tag: Jim Malatras

Auto Draft

Malatras resigns after intense scrutiny, but will collect $450,000 in 2022, followed by $186,000 annually

Former SUNY Chancellor Jim Malatras is done. He was granted a yearlong ‘study-leave’ with SUNy, which means Malatras will collect a $450,000 salary with benefits. He will also continue to be eligible for the state retirement system. Following that year-long hiatus, he ... MORE
SUNY Chancellor Malatras could receive $450,000 one-time severance, $245,000 annual salary after resignation

SUNY Chancellor Malatras could receive $450,000 one-time severance, $245,000 annual salary after resignation

SUNY Chancellor Jim Malatras stands to make a lot of money in the coming months, according to his contract, which is ‘under review’. The Albany Times-Union reported this week that Malatras is eligible for a $450,000 one-year paid leave and lifetime employment ... MORE
Auto Draft

Embattled SUNY Chancellor James Malatras resigns

Embattled SUNY Chancellor James Malatras has resigned. The resignation came after days of bad press for the former Cuomo official. “The recent events surrounding me over the past week have become a distraction over the important work that needs to be accomplished ... MORE
Auto Draft

Should SUNY Chancellor Malatras resign or be fired over actions while working for former Governor Andrew Cuomo?

UPDATE : Malatras has announced his resignation, effective January 14th Calls are growing louder for SUNY Chancellor Jim Malatras to resign. He’s come under fire for things said while working in former Governor Andrew Cuomo’s administration. Before Cuomo’s resignation- and since- the ... MORE
Cuomo’s top aides, including DeRosa, Lacewell, Malatras accused of altering health dept. reports on nursing homes

Cuomo’s top aides, including DeRosa, Lacewell, Malatras accused of altering health dept. reports on nursing homes

Top aides to Gov. Andrew Cuomo are accused of rewriting a report put together by top state health officials to hide the true number of nursing home deaths due to COVID-19, according to the New York Times and Wall Street Journal. Both ... MORE